Teva Reports Fourth Quarter and Full Year 2021 Financial Results | Business Wire
Teva | Partnership | Direct Relief
Teva Reports Third Quarter 2020 Financial Results | Business Wire
Teva Pharmaceutical S&P rating outlook changed to stable | Seeking Alpha
Moody's Downgrades Teva Bond Rating to “Junk” | Ctech
Credit Trends: Downgrade Potential Rises To All-Time High On Sharp, Deep Economic Slowdown | S&P Global Ratings
Fitch Downgrades Teva to Junk Rating | Ctech
Teva's Credit Rating Cut to Junk by Fitch - Bloomberg
Teva Pharmaceuticals has acquired success with Actavis Generics | World Finance
Teva Pharmaceutical Industries Limited Credit Ratings :: Fitch Ratings
DEF 14A
Credit Trends: Downgrade Potential Rises To All-Time High On Sharp, Deep Economic Slowdown | S&P Global Ratings
Teva Faces Rocky Path to Recovery After Debt | Fortune
S&P Global Ratings affirms Teva Pharmaceutical Industries at "BB-" (Local Currency LT credit rating); outlook stable
Teva Reports Fourth Quarter and Full Year 2020 Financial Results | Business Wire
Teva Pharm to stay as unified drugmaker, sees big interest in API business, says CEO
S&P cuts Teva's rating on rising litigation risks - Globes
Teva Pharmaceutical Industries Ltd (ADR) Needs More Than Job Cuts
Teva's Debt Cut to Junk by Moody's, Adding to Drugmaker's Woes - Bloomberg
Teva shares approach 20-year low amid Moody's warning and other woes | Fierce Pharma
Teva's Debt Cut to Junk by Moody's, Adding to Drugmaker's Woes - Bloomberg
Teva Shut Down New York, Washington Offices, Says CEO | Ctech
